Literature DB >> 17121172

Forgetfulness: a role in noncompliance with antidepressant treatment.

Andrew G Bulloch1, Carol E Adair, Scott B Patten.   

Abstract

OBJECTIVES: To determine the degree of noncompliance with antidepressant treatment in the Alberta population and to investigate the reasons for noncompliance.
METHOD: We used data from the Alberta Mental Health Survey, a telephone survey conducted in 2003 (n = 5323 adults), to produce population-based estimates of the frequency of noncompliance and the reported reasons for noncompliance.
RESULTS: Reported noncompliance was 41.7% (95% confidence interval [CI], 36.9% to 46.6%) for respondents taking 1, 2, or 3 antidepressants. Noncompliance for those taking 1 antidepressant was 42.0% (95%CI, 36.9% to 47.2%), whereas noncompliance for those taking 2 or 3 antidepressants was 39.4% (95%CI, 26.7% to 53.6%). Among respondents currently taking at least one antidepressant, 64.9% (95%CI, 57.4% to 71.7%) reported that forgetfulness was the most common reason for noncompliance. Of respondents taking 1 medication, 64.1% (95%CI, 56.0% to 71.4%) reported forgetfulness as did 71.3% (95%CI, 48.3% to 86.8%) of those taking 2 or 3 medications. Both the frequency of noncompliance and the reported reasons for noncompliance were independent of sex and age.
CONCLUSION: Our study replicates prior reports that indicate that noncompliance is common with antidepressant treatment. Forgetting to take medication is the most important reported reason for this noncompliance.

Mesh:

Substances:

Year:  2006        PMID: 17121172     DOI: 10.1177/070674370605101110

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  6 in total

1.  Non-adherence with psychotropic medications in the general population.

Authors:  Andrew G M Bulloch; Scott B Patten
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-04-04       Impact factor: 4.328

2.  Depression, medication adherence, and service utilization in systemic lupus erythematosus.

Authors:  Laura J Julian; Edward Yelin; Jinoos Yazdany; Pantelis Panopalis; Laura Trupin; Lindsey A Criswell; Patricia Katz
Journal:  Arthritis Rheum       Date:  2009-02-15

3.  Factors that influence adherence with disease-modifying therapy in MS.

Authors:  Katherine Treadaway; Gary Cutter; Amber Salter; Sharon Lynch; James Simsarian; John Corboy; Douglas Jeffery; Bruce Cohen; Ken Mankowski; Joseph Guarnaccia; Lawrence Schaeffer; Roy Kanter; David Brandes; Charles Kaufman; David Duncan; Ellen Marder; Arthur Allen; John Harney; Joanna Cooper; Douglas Woo; Olaf Stüve; Michael Racke; Elliot M Frohman
Journal:  J Neurol       Date:  2009-04-27       Impact factor: 4.849

4.  Assessing patient preferences for delivery of reminders on scheduled visits in a psychiatry ambulatory service.

Authors:  Dongwen Wang; John Crilly; Louanne Jaeger; Glenn Palmer
Journal:  AMIA Annu Symp Proc       Date:  2007-10-11

Review 5.  Achieving adolescent adherence to treatment of major depression.

Authors:  Dennis Staton
Journal:  Adolesc Health Med Ther       Date:  2010-08-04

6.  Assessing forgetfulness and polypharmacy and their impact on health-related quality of life among patients with hypertension and dyslipidemia in Greece during the COVID-19 pandemic.

Authors:  Kyriakos Souliotis; Theodoros V Giannouchos; Chistina Golna; Evangelos Liberopoulos
Journal:  Qual Life Res       Date:  2021-06-22       Impact factor: 3.440

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.